FDA Investigation of Bogus Canadian Rx Website Results in Call for <br>Renewed Caution When Shopping Online

FDA investigators who shopped for “generic” pharmaceuticals at a purported Canadian website found substandard or altered products across the board. Safety checks such as refusing to provide a pharmaceutical product that would have put the user at risk, given their self-disclosed list of current medications, were also lacking. The FDA “shopped” at a website advertising generic productsfor brand- name pharmaceuticals for which no generics have been approved. Once the purchased products arrived at the FDA, they underwent laboratory testing and were found to contain either too much or not enough active ingredient. The FDA urges consumers who choose to purchase medications online to do so only from websites displaying the “VIPPS” seal, a quality-control program of the National Association of Boards of Pharmacy.